참고문헌
- M.M. Meshali, H.M. Abdel-Aleem, F.M. Sakr, S. Nazzal and Y. El-Malah, In vitro phonophoresis: effect of ultrasound intensity and mode at high frequency on NSAIDs transport across cellulose and rabbit skin membranes, Pharmazie., 63, 49-53 (2008)
- J. Czares-Delgadillo, A. Naik, Y.N. Kalia, D. Quintanar-Guerrero and A. Ganem-Quintanar, Skin permeation enhancement by sucrose esters: a pH-dependent phenomenon, Int. J. Pharm., 297, 204-212 (2005) https://doi.org/10.1016/j.ijpharm.2005.03.020
- G.P. Agrawal, M. Juneja, S. Agrawal, S.K. Jain and S.S. Pancholi,, Preparation and characterization of reverse micelle based organogels of piroxicam, Pharmazie., 59, 191-193 (2004)
- A. Doliwa, S. Santoyo and P. Ygartua, Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes, Drug Dev. Ind. Pharm., 27, 751-758 (2001) https://doi.org/10.1081/DDC-100107238
- E. Beetge, J. du Plessis, D.G. Mller, C. Goosen and F.J. van Rensburg, The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID's on their transdermal absorption, Int. J. Pharm., 193, 261-264 (2000) https://doi.org/10.1016/S0378-5173(99)00340-3
- Y. Yuan, X. Chen and D. Zhong, Determination of meloxicam in human plasma by liquid chromatographytandem mass spectrometry following transdermal administration, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 852, 650-654 (2007) https://doi.org/10.1016/j.jchromb.2007.01.036
- T. Penzes, G. Blazso, Z. Aigner, G. Falkay and I. Eros, Topical absorption of piroxicam from organogels-in vitro and in vivo correlations, Int. J. Pharm., 298, 47-54 (2005) https://doi.org/10.1016/j.ijpharm.2005.03.013
- A. Doliwa, S. Santoyo, M.A. Campanero and P. Ygartua, Sensitive LC determination of piroxicam after in vitro transdermal permeation studies, J. Pharm. Biomed. Anal., 26, 531-537 (2001) https://doi.org/10.1016/S0731-7085(01)00455-1
- I. Csoka, E. Csanyi, G. Zapantis, E. Nagy, A. Fehr-Kiss, G. Horvth, G. Blazs and I. Eros, In vitro and in vivo percutaneous absorption of topical dosage forms: case studies, Int. J. Pharm., 291, 11-19 (2005) https://doi.org/10.1016/j.ijpharm.2004.07.038
- S.N. Murthy, Y.L. Zhao, A. Sen and S.W. Hui, Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation, J. Control. Release., 99, 393-402 (2004) https://doi.org/10.1016/j.jconrel.2004.07.026
- C. Curdy, Y.N. Kalia, A. Naik and R.H. Guy, Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion, J. Control. Release., 76, 73-79 (2001) https://doi.org/10.1016/S0168-3659(01)00418-7
- E. Larrucea, A. Arellano, S. Santoyo and P. Ygartua, Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin, Eur. J. Pharm. Biopharm., 52, 113-119 (2001) https://doi.org/10.1016/S0939-6411(01)00158-8
- J.A. Cordero, M. Camacho, R. Obach, J. Domenech and L. Vila, In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs, Eur. J. Pharm. Biopharm., 51, 135-142 (2001) https://doi.org/10.1016/S0939-6411(00)00149-1
- C. Rasetti-Escargueil and V. Grange, Pharmacokinetic profiles of two tablet formulations of piroxicam, Int. J. Pharm., 295, 129-134 (2005) https://doi.org/10.1016/j.ijpharm.2005.02.006